Pharmacovigilance Blog

ICSR Management

Linking ICSR Cases: A Valid Criteria

In this comprehensive blog, we explore what case linking means in the context of ICSR cases and also explain the criteria for linking cases.

Bala

Read

ICSR Management

What is Case Receipt in Pharmacovigilance?

Welcome to the next installment of our ICSR category series in our blog, where we delve into the definitions of various receipt dates in ICSR case processing.

Bala

Read

MedDRA Series

MedDRA: Identifying the Closest LLTs

In this comprehensive blog, we delve into key tips for effectively performing MedDRA coding, addressing common sources of confusion. Here are a few valuable tips worth exploring.

Bala

Read

ICSR Management

Exploring the Origins: Sources of ICSR reports

In this article, we delve into the scope and purpose of ICSR reports, shedding light on the reporters involved and the sources they draw upon. If you’re interested in gaining a deeper understanding of pharmacovigilance, this article is sure to provide valuable insights.

Bala

Read

Drug safety and pharmacovigilance

❇ Thalidomide incident and pharmaceutical industry

Welcome to our comprehensive blog where we delve into the transformative impact of thalidomide and its lasting influence on the cost burden of drugs in our society today. Gain a deep understanding of how the incident reshaped the way we approach drug development, testing, and regulation.

Bala

Read

ICSR Management

Expedited Safety Reporting: Everything you need to know

In this blog, you will learn the term what is expedited reporting mean in the field of pharmacovigilance, including its standards and requirements. We delve into the time-frames associated with different types of reports, ensuring that you have a clear understanding of the urgency.

Bala

Read

ICSR Management

Understanding SUSAR cases: How it differs from other serious cases?

Welcome to our enlightening blog, where we explore the distinction between SUSAR (Suspected Unexpected Serious Adverse Reaction) cases and other serious cases, highlighting their unique characteristics and significance.

Bala

Read

Exploring Adverse Events

╰┈➤ Drug Interactions: An Adverse Event

In this comprehensive blog, we decode the conventions for assessing and coding drug interactions as adverse events in pharmacovigilance case processing. Click to learn more in detail.

Bala

Read